Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
about
Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancerHepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic TargetMicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.DACH1 suppresses breast cancer as a negative regulator of CD44.The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2.Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma.Hook1 inhibits malignancy and epithelial-mesenchymal transition in hepatocellular carcinoma.Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC CellsTargeting interlukin-6 to relieve immunosuppression in tumor microenvironment.Fentanyl Promotes Breast Cancer Cell Stemness and Epithelial-Mesenchymal Transition by Upregulating α1, 6-Fucosylation via Wnt/β-Catenin Signaling Pathway.Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue.Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression.TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.Isolation of Stem-Like Cancer Cells in Primary Endometrial Cancer Using Cell Surface Markers CD133 and CXCR4.CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma.Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma.I131 reinforces antitumor activity of metuximab by reversing epithelial-mesenchymal transition via VEGFR-2 signaling in hepatocellular carcinoma.Comparison of EMT mediated tyrosine kinase inhibitor resistance in NSCLC.The role of cancer-associated fibroblast MRC-5 in pancreatic cancer.NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells.FOXA2 promotes the proliferation, migration and invasion, and epithelial mesenchymal transition in colon cancer.WWC3 inhibits epithelial-mesenchymal transition of lung cancer by activating Hippo-YAP signaling.Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathwayCircular RNA: new star, new hope in cancerTSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosisLysyl hydroxylases are transcription targets for GATA3 driving lung cancer cell metastasis
P2860
Q28079205-254B8A33-9FBA-4178-B39C-D73DDE8D2767Q33565746-79BF0D9A-DDD4-43A2-9890-AE4DCA248AD8Q33792251-FD860343-6E1A-49BA-8347-515A2F6DCD4EQ33849252-E72CAF9D-54DF-498E-B858-26FCD8B86355Q33875858-6C06EB79-2FDD-492E-BB96-D75EB34C7E0BQ37578210-8002DE77-B09B-47CE-A662-66983BEEDFEEQ38697003-BA8BCABD-59D9-462B-ADB9-672E534523E8Q38705051-422C5BC9-37C3-4C9B-97DA-C3BD0AD7B4D3Q39390630-00CBAAA6-B9EF-4351-A518-C3272DEA5891Q41124448-828E9BD1-0540-4797-A9D5-7B047ACC6E97Q41204113-22802327-E4F4-4C99-ACCB-152E1375C7B5Q41809872-0DDFCE94-7E25-481B-80C2-B3E582D2098CQ46405945-94CCBEEE-67A3-4D19-B05E-9C4BC4AC81CCQ47134730-D6E846D7-3EEE-4F89-80F8-1E3ACB9C7206Q47145675-F1F51F9F-A22E-4055-AAD6-AB42D533C4C9Q47303229-888ED053-4E63-4B2D-94D5-DF08CAD6F7F2Q47395337-03394D8F-8375-4918-8F35-003D916A744AQ48169631-05EE82D6-C673-4F75-9251-AA6EFBC4FF35Q50033862-808D8198-63A7-4C0D-A7A1-1E5C019CB657Q50323934-0550A89B-BE95-4894-9F49-E5482D4F4BF3Q51767137-8B76E5E3-E4FC-403D-B15F-FC2296BFD3EBQ55347208-FA892E69-3EBE-4C0B-9BAA-CA3CF9C62B04Q55393865-8037CB64-F535-46B0-81A8-117A8294296BQ57067452-CFE94081-CB3A-469F-B92C-53C3C5AC9A5DQ58736691-9F68F8C7-865C-4074-8E79-F429CC15BC71Q58793650-BD752A7F-45C9-40E6-8EC4-11B6D1530915Q58793744-F8EF5B4F-C07C-41AE-AE71-8990AFAE1430
P2860
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Epithelial-to-mesenchymal plas ...... ts in hepatocellular carcinoma
@ast
Epithelial-to-mesenchymal plas ...... ts in hepatocellular carcinoma
@en
Epithelial-to-mesenchymal plas ...... ts in hepatocellular carcinoma
@nl
type
label
Epithelial-to-mesenchymal plas ...... ts in hepatocellular carcinoma
@ast
Epithelial-to-mesenchymal plas ...... ts in hepatocellular carcinoma
@en
Epithelial-to-mesenchymal plas ...... ts in hepatocellular carcinoma
@nl
prefLabel
Epithelial-to-mesenchymal plas ...... ts in hepatocellular carcinoma
@ast
Epithelial-to-mesenchymal plas ...... ts in hepatocellular carcinoma
@en
Epithelial-to-mesenchymal plas ...... ts in hepatocellular carcinoma
@nl
P2860
P921
P3181
P1476
Epithelial-to-mesenchymal plas ...... ts in hepatocellular carcinoma
@en
P2093
Aparna Jayachandran
P2860
P2888
P3181
P356
10.1186/S13045-016-0307-9
P407
P5008
P577
2016-08-30T00:00:00Z
P6179
1037167153